{"id":"NCT03213457","sponsor":"AbbVie","briefTitle":"A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain","officialTitle":"A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination With Estradiol/Norethindrone Acetate in Subjects With Moderate to Severe Endometriosis-Associated Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-07-07","primaryCompletion":"2020-03-27","completion":"2023-12-06","firstPosted":"2017-07-11","resultsPosted":"2021-04-20","lastUpdate":"2024-12-20"},"enrollment":681,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Endometriosis"],"interventions":[{"type":"DRUG","name":"Estradiol/Norethindrone Acetate","otherNames":["Activella","E2/NETA"]},{"type":"DRUG","name":"Placebo for Elagolix","otherNames":[]},{"type":"DRUG","name":"Elagolix","otherNames":["ABT-620","Elagolix Sodium","ORILISSA"]},{"type":"DRUG","name":"Placebo for E2/NETA","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Elagolix / Elagolix + E2/NETA","type":"EXPERIMENTAL"},{"label":"Elagolix + E2/NETA","type":"EXPERIMENTAL"}],"summary":"The objective of this study is to evaluate safety and efficacy of elagolix in the management of moderate to severe endometriosis-associated pain in adult premenopausal female participants including the safety and efficacy of elagolix in combination with concomitant hormonal add-back therapy.","primaryOutcome":{"measure":"Co-Primary Endpoint: Percentage of Participants With a Response for Dysmenorrhea (DYS) at Months 6 and 12 Based on Daily Assessment","timeFrame":"Month 6, Month 12","effectByArm":[{"arm":"Placebo","deltaMin":23.7,"sd":null},{"arm":"Elagolix + E2/NETA","deltaMin":62.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"},{"comp":"OG000 vs OG001","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":8},"locations":{"siteCount":197,"countries":["United States","Canada","Puerto Rico"]},"refs":{"pmids":["34435897"],"seeAlso":["https://www.rxabbvie.com/"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":194},"commonTop":["HOT FLUSH","NAUSEA","HEADACHE","SINUSITIS","URINARY TRACT INFECTION"]}}